Purchases and Sales Made in Q1 2024 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q1 2024. The information is specifically focused on institutions that hold shares of Revance Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-240K- 30.65% |
$1.12M - $2.24M
|
543K
$1.4M
|
|
|
Apr 29, 2024
Q1 2024
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-249K- 92.26% |
$1.16M - $2.32M
|
20.9K
$53.6K
|
|
|
May 15, 2024
Q1 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-270K- 88.37% |
$1.26M - $2.51M
|
35.5K
$91.3K
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-303K- 85.67% |
$1.41M - $2.82M
|
50.7K
$130K
|
|
|
May 15, 2024
Q1 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-306K- 32.95% |
$1.42M - $2.85M
|
622K
$1.6M
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.49M- 32.09% |
$6.93M - $13.9M
|
3.15M
$8.1M
|
|
|
May 14, 2024
Q1 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-1.55M- 96.82% |
$7.22M - $14.4M
|
50.9K
$131K
|